Nozomu Koyanagi Selected Research

ER37328

1/2003	A novel carbazole topoisomerase II poison, ER-37328: potent tumoricidal activity against human solid tumors in vitro and in vivo.
1/2002	Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nozomu Koyanagi Research Topics

Disease

3	Neoplasms (Cancer) 09/2004 - 01/2002
2	Leukemia P388 09/2004 - 01/2002
1	Hepatocellular Carcinoma (Hepatoma) 08/2011
1	Sarcoma (Soft Tissue Sarcoma) 09/2004
1	Body Weight (Weight, Body) 09/2004
1	Mouth Neoplasms (Oral Cancer) 09/2004
1	Carcinoma (Carcinomatosis) 01/2002

Drug/Important Bio-Agent (IBA)

2	carbazoleIBA 09/2004 - 01/2003
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2003 - 01/2002
2	ER37328IBA 01/2003 - 01/2002
2	Etoposide (VP 16)FDA LinkGeneric 01/2003 - 01/2002
1	Vitamin K 2 (Vitamin K2)IBA 08/2011
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 09/2004
1	Cisplatin (Platino)FDA LinkGeneric 01/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2003
1	montirelin (NS-3)IBA 01/2003
1	trioctyl phosphine oxide (TOPO)IBA 01/2003
1	PoisonsIBA 01/2003
1	Dihydrotachysterol (AT 10)IBA 01/2002
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2002

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2002